Clinical trial

The Effect of Ketamine on Attentiveness

NCT01165294

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-10-01

PhasePHASE1

Study timeline

Study start (unknown)2009-10-01Date precision: month

Registry last updated2010-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

PlaceboDRUG

ketamineDRUG · verified · RxNorm: ketamine

Sponsors & collaborators

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01165294 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.